Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services.
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Hovione, the leader in spray drying and particle engineering, announced today an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
News release, 18 February 2022
This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy
Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives
A strategic partnership that will take Hovione to new technology frontiers.
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction